IQVIA HOLDINGS INC. Payments of Merger Related Costs, Financing Activities
IQVIA HOLDINGS INC. (IQV) reported Payments of Merger Related Costs, Financing Activities of $4.00 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-16.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfMergerRelatedCostsFinancingActivities · last filed 2018-02-16
- IQVIA HOLDINGS INC. payments of merger related costs, financing activities for fiscal 2017 was $4.00M, a 20.00% decline from fiscal 2016.
- IQVIA HOLDINGS INC. payments of merger related costs, financing activities for fiscal 2016 was $5.00M, a 66.67% increase from fiscal 2015.
- IQVIA HOLDINGS INC. payments of merger related costs, financing activities for fiscal 2015 was $3.00M, a 0.00% change from fiscal 2014.
- IQVIA HOLDINGS INC. payments of merger related costs, financing activities for fiscal 2014 was $3.00M.
| Period end | Payments of Merger Related Costs, Financing Activities 12 month |
|---|---|
| 2017-12-31 | $4.00M 10-K · filed 2018-02-16 |
| 2016-12-31 | $5.00M 10-K · filed 2018-02-16 |
| 2015-12-31 | $3.00M 10-K · filed 2018-02-16 |
| 2014-12-31 | $3.00M 10-K · filed 2017-02-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |